Myriad Genetics | MYGN - Market Capitalization


Myriad Genetics reported $412.5M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 37.86B 3.64B Dec/2025
Becton, Dickinson and Co. USD 55.29B 1.64B Dec/2025
Bruker USD 7.16B 2.23B Dec/2025
Danaher USD 161.7B 29.34B Dec/2025
Hologic USD 16.62B 1.67B Dec/2025
Illumina USD 20.62B 6.53B Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Mettler Toledo International USD 28.48B 3.19B Dec/2025
OraSure Technologies USD 219M 45M Mar/2026
Pacific Biosciences Of California USD 356M 209M Mar/2026
Quest Diagnostics USD 19.3B 2.01B Dec/2025
Quidel USD 1.99B 66M Dec/2025
Repligen USD 9.22B 1.7B Dec/2025
Revvity USD 10.97B 1.21B Dec/2025
Standard Biotools USD 497M 63M Sep/2025
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025
Veracyte USD 3.33B 627M Dec/2025
Waters USD 22.61B 5.25B Dec/2025